---
title: "Nukkleus Signs Multiple Material Agreements"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272843564.md"
description: "Nukkleus has signed definitive agreements to acquire Nimbus Drones, an Israeli aerospace robotics company, for 1,850,000 restricted common shares and a $3.25 million convertible note. The note has a 6% interest rate, matures in 24 months, and is convertible at $2.00 per share with a 4.99% ownership cap. This acquisition aims to enhance Nukkleus's presence in industrial drone applications while managing cash outlay. The agreements were signed with Elad Defense and are effective from January 15, 2026."
datetime: "2026-01-16T13:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272843564.md)
  - [en](https://longbridge.com/en/news/272843564.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272843564.md)
generator: "portal-rs"
---

# Nukkleus Signs Multiple Material Agreements

Nukkleus signed definitive agreements to acquire Nimbus Drones, an Israeli aerospace robotics company focused on professional unmanned aerial systems, and to issue a related convertible note to the seller. The stock purchase agreement transfers 100% of Nimbus to Nukkleus in exchange for 1,850,000 restricted common shares and a $3.25 million note. The note carries 6% interest, matures in 24 months, is convertible at $2.00 per share, and includes a 4.99% ownership cap. The deals broaden Nukkleus's presence in critical industrial drone applications while managing cash outlay.

**Agreement 1: Nukkleus Signs Stock Purchase Agreement With Elad Defense**

-   **Agreement type**: Stock purchase agreement for 100% acquisition of Nimbus Drones
-   **Counterparty**: Elad Defense
-   **Signed / Effective**: Jan 15 2026 / same
-   **Reason**: Expand into professional unmanned aerial systems

**Agreement 2: Nukkleus Signs Convertible Note Agreement With Elad Defense**

-   **Agreement type**: 6% 24-month convertible note ($3.25M; $2.00 conversion; 4.99% cap)
-   **Counterparty**: Elad Defense
-   **Signed / Effective**: Jan 15 2026 / same
-   **Duration / Termination**: 24 months
-   **Reason**: Support acquisition consideration and preserve cash

Original SEC Filing: Nukkleus Inc. \[ NUKK \] - 8-K - Jan. 16, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [NUKK.US](https://longbridge.com/en/quote/NUKK.US.md)
- [DFNS.US](https://longbridge.com/en/quote/DFNS.US.md)

## Related News & Research

- [Results: Billerud AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates](https://longbridge.com/en/news/302983070.md)
- [Kuehne + Nagel International AG - Depositary receipt consensus price target raised 13.43% to $52.60](https://longbridge.com/en/news/302982717.md)
- [Marqeta (MQ) Expands With Square And Coinbase, Is The Stock Still Undervalued?](https://longbridge.com/en/news/302983307.md)
- [Is Elevance Health (ELV) Still Undervalued Following Strong Earnings And Higher 2026 Guidance?](https://longbridge.com/en/news/302983253.md)
- [Moderna, Inc. $MRNA Shares Sold by IFP Advisors Inc](https://longbridge.com/en/news/303041682.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**